As of 2024-09-09, the Relative Valuation of FibroGen Inc (FGEN) is (63.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.39 USD, the upside of FibroGen Inc based on Relative Valuation is -16358.8%.
The range of the Relative Valuation is (73.43) - (51.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 43.8x - 55.0x | 49.4x |
| Forward P/E multiples | 21.7x - 30.8x | 26.2x |
| Fair Price | (73.43) - (51.63) | (63.41) |
| Upside | -18927.1% - -13339.1% | -16358.8% |
| Date | P/E |
| 2024-09-06 | -0.23 |
| 2024-09-05 | -0.25 |
| 2024-09-04 | -0.24 |
| 2024-09-03 | -0.20 |
| 2024-08-30 | -0.22 |
| 2024-08-29 | -0.22 |
| 2024-08-28 | -0.22 |
| 2024-08-27 | -0.23 |
| 2024-08-26 | -0.24 |
| 2024-08-23 | -0.24 |
| 2024-08-22 | -0.23 |
| 2024-08-21 | -0.24 |
| 2024-08-20 | -0.25 |
| 2024-08-19 | -0.23 |
| 2024-08-16 | -0.22 |
| 2024-08-15 | -0.22 |
| 2024-08-14 | -0.22 |
| 2024-08-13 | -0.23 |
| 2024-08-12 | -0.23 |
| 2024-08-09 | -0.24 |
| 2024-08-08 | -0.26 |
| 2024-08-07 | -0.27 |
| 2024-08-06 | -0.26 |
| 2024-08-05 | -0.27 |
| 2024-08-02 | -0.26 |
| 2024-08-01 | -0.28 |
| 2024-07-31 | -0.32 |
| 2024-07-30 | -0.61 |
| 2024-07-29 | -0.67 |
| 2024-07-26 | -0.69 |
| 2024-07-25 | -0.73 |
| 2024-07-24 | -0.75 |
| 2024-07-23 | -0.74 |
| 2024-07-22 | -0.75 |
| 2024-07-19 | -0.63 |
| 2024-07-18 | -0.62 |
| 2024-07-17 | -0.64 |
| 2024-07-16 | -0.68 |
| 2024-07-15 | -0.63 |
| 2024-07-12 | -0.62 |
| 2024-07-11 | -0.58 |
| 2024-07-10 | -0.54 |
| 2024-07-09 | -0.50 |
| 2024-07-08 | -0.48 |
| 2024-07-05 | -0.43 |
| 2024-07-03 | -0.41 |
| 2024-07-02 | -0.44 |
| 2024-07-01 | -0.46 |
| 2024-06-28 | -0.53 |
| 2024-06-27 | -0.61 |